Table 4.

Reconstituting Ability of Fresh Bone Marrow and Day 7 or Day 21 Cultured Cells

CytokinesDays of IncubationNo. of Cells InjectedNo. of CFU-C Injected% Ly5.1 (donor) PB Cells4-150
2 mo4 mo
Fresh marrow  100 42 51.3 ± 14.1 52.3 ± 20.8 
FL, IL-11 1.6 × 104 ND 50.5 ± 8.3 40.1 ± 8.60 
KL, IL-11 2.0 × 105 ND 63.4 ± 12.2 44.7 ± 16.9 
FL, IL-11 21 3.4 × 107 34,100 47.3 ± 8.5 36.2 ± 16.8 
KL, IL-11 21 3.2 × 107 9,200 16.3 ± 2.5 11.7 ± 2.2 
CytokinesDays of IncubationNo. of Cells InjectedNo. of CFU-C Injected% Ly5.1 (donor) PB Cells4-150
2 mo4 mo
Fresh marrow  100 42 51.3 ± 14.1 52.3 ± 20.8 
FL, IL-11 1.6 × 104 ND 50.5 ± 8.3 40.1 ± 8.60 
KL, IL-11 2.0 × 105 ND 63.4 ± 12.2 44.7 ± 16.9 
FL, IL-11 21 3.4 × 107 34,100 47.3 ± 8.5 36.2 ± 16.8 
KL, IL-11 21 3.2 × 107 9,200 16.3 ± 2.5 11.7 ± 2.2 

Irradiated recipients (5 mice per group) were transplanted with 100 fresh LinSca-1+c-kit+ cells or with the whole fractions of day 7 or day 21 cultured cells that had been initiated with 100 LinSca-1+c-kit+ cells.

F4-150

Mean ± SD % donor-derived nucleated peripheral blood cells identified by anti-Ly5.1. Background (peripheral blood cells of nontransplanted female mice) staining was <1.0%.

or Create an Account

Close Modal
Close Modal